August 15 - 18
Grand Hyatt Washington, Washington, D.C.
Meet with Flagship at the Next Generation Dx Summit 2017 to discover how we help drug developers define their path to success. Our computational Tissue Analysis (cTA™) approach provides the quantitative, contextual data needed to make confident clinical trials decisions. We partner with drug developers to implement tissue-based biomarker strategies and drive efficient and effective clinical trials.
Look for our booth, #415, at this important conference to discuss your needs in clinical trial decision support.